ClinicsDoctorsTreatmentsResourcesWho we areAsk PATHAbove-average outcomes — strongest for ages 38-39.
Based on age-adjusted HFEA live-birth data (2016–18) vs the UK national average.
Your question about this clinic travels with you — after sign-up it's waiting as the start of your first PATH conversation.
Wessex at Poole (TFP Wessex) presents as a clinic with a strong, personable front-line culture and clear clinical capacity, but also with some operational inconsistencies that affect patient trust. Multiple reviewers emphasise a warm welcome, compassionate staff and a consistently respectful attitude from reception teams, nurses and doctors. Specific members of staff are remembered by name — for example a nurse whose kindness and attentiveness helped a patient tolerate painful procedures — and several families report life-changing successful outcomes (newborn children) that they explicitly attribute to the clinic's care. That combination of skilled teams and memorable, hands-on nursing is a recurring positive theme and underpins overall high patient satisfaction for many users. Communication is generally described as informative: patients say the team kept them updated about options and were supportive through what can be a worrying process. This indicates good routine patient communication and education around treatment pathways. Clinical expertise is visible in the presence of multi-disciplinary staff (doctors, embryologists, anaesthetists and nursing) and in the successful pregnancies reported. Embryology support is implicitly trusted where fertilisation rates and embryo handling are discussed, and the availability of anaesthetists suggests readiness to provide procedures requiring sedation or anaesthesia. At the same time, clinical decision-making and treatment recommendations have been a point of friction for some patients. One reviewer reports a perceived push toward additional interventions (notably ICSI) and purchased medication that did not improve outcomes, with a consequent drop in fertilisation compared with a prior cycle elsewhere. Another patient felt discouraged from pursuing PGT testing. These comments point to a perceived variable alignment between individualized treatment tailoring and commercial/clinic pathways, which can erode confidence when outcomes disappoint. Emotional support is a clear strength: multiple accounts note compassionate staff and a sense of being well looked after. However, administrative and billing issues surface as an area needing attention — duplicated or unnecessary prescriptions and out-of-pocket medication costs were raised, as were medication errors in one account. These operational lapses, although not ubiquitous, are significant because they affect trust, financial burden and perceived quality. Wait-time and appointment experiences are not extensively detailed but reception praise suggests front-desk interactions are generally positive. Recurring themes are strong interpersonal care and clinical competence, juxtaposed with occasional medication/administration mistakes and dissatisfaction with some treatment recommendations. For prospective patients, Wessex at Poole appears to offer committed staff and demonstrable positive clinical outcomes, but those considering private treatment should discuss medication plans, costs, and the rationale for specific interventions (e.g., ICSI, PGT) in detail to ensure the pathway is tailored to their prior history and expectations.
Source: HFEA regulated data. Best age band: 38-39. Weakest: 35-37.
No cost details listed for this clinic. Contact the clinic directly for an indicative quote.
Patient-review insights for this clinic aren't ingested yet. The HFEA-regulated outcomes shown elsewhere on this page are the most reliable signal until then.
We don't yet have a verified consultant list for this clinic. Browse the full doctors directory for GMC-registered specialists.
Written in PATH's voice from this clinic's published HFEA data — reviewed before publishing, never generated live.
Wessex at Poole's overall live-birth rate is 43%, above the national average of 36% — a gap of 7 percentage points. Looking by age, the 38-39 band does best at 31% against a national 26%, while 35-37 is weaker at 16% against a national 32%. The clinic carries a low volume of cycles, so results here can shift more from year to year than at a larger centre. Worth asking how your own age band has fared in recent data.
The headline number is a live-birth rate per embryo transferred, drawn from HFEA-verified regulated data covering 2016 to 2018. Two checks are worth making before comparing it against another clinic: whether the figure is per embryo transferred or per cycle started, since the two can diverge, and which years the data covers, as reporting periods vary by clinic. Both affect whether the comparison is a fair one to draw.
A few things worth putting to the team directly: what is included in the quoted price and which add-on costs tend to come up, their live-birth rates for your specific age group in the latest HFEA data, and how many cycles like yours they see each year given the caseload here is on the smaller side. A good consultant will welcome these questions rather than wave them away.
These answers use published data only — PATH personalizes once it knows your age, your numbers, and your story.
Ready to start your journey? Contact the clinic directly.
Ask PATH if this clinic fits youRequest ConsultationOpens in the app — you'll create a free account first.
Compare ClinicsfertilityPATH earns no referral fees. We recommend clinics based on data, not commercial relationships.
